Effect of spironolactone, thiomestrone and dimercaprol on the toxicity, retention and distribution of mercury in the mouse.
D000736:Androstenes / Q000494:pharmacology*; D000737:Androstenols / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000931:Antidotes / Q000494:pharmacology / Q000627:therapeutic use; D001921:Brain / Q000378:metabolism; D004064:Digestive System / Q000378:metabolism; D004112:Dimercaprol / Q000494:pharmacology* / Q000627:therapeutic use; D004336:Drug Antagonism; D007664:Ketosteroids / Q000494:pharmacology / Q000627:therapeutic use; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008297:Male; D008628:Mercury / Q000378:metabolism*; D008629:Mercury Isotopes; D008630:Mercury Poisoning / Q000188:drug therapy; D051379:Mice; D013148:Spironolactone / Q000494:pharmacology* / Q000627:therapeutic use; D013154:Spleen / Q000378:metabolism; D013440:Sulfides / Q000494:pharmacology / Q000627:therapeutic use; D013737:Testis / Q000378:metabolism
D000736:Androstenes; D000737:Androstenols; D000931:Antidotes; D007664:Ketosteroids; D008629:Mercury Isotopes; D013440:Sulfides; D004112:Dimercaprol; D013148:Spironolactone; D008628:Mercury